ENTITY

Avidity Biosciences (RNA US)

12
Analysis
Health Care • United States
Avidity Biosciences LLC operates as a biotechnology company. The Company develops and discovers novel antibody oligonucleotide conjugates therapeutics that overcome current barriers to the delivery of oligonucleotides and unlock their potential to treat a wide range of serious diseases. Avidity Biosciences serves customers in the United States.
more
Exchange Announcement • 09 Oct 2026 18:17

Current Report (Amendment) (Form 8-K/A | Period ending 2026-10-07)

Exchange Announcement • 08 Oct 2026 18:52

Current Report (Form 8-K | Period ending 2026-10-07)

Exchange Announcement • 13 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 15 Jul 2026 05:14

Current Report (Form 8-K | Period ending 2026-07-14)

Exchange Announcement • 15 May 2026 04:51

Quarterly Report (Form 10-Q | Period ending 2026-03-31)

x